MARY RUDLOFF: Open Payments
NPI 1407841356 · FREDONIA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,327 in 50 payments from 13 companies in 2025. Trend: 2023 $1,198 · 2024 $1,521 · 2025 $1,327
Food & beverage: $1,327
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $301 |
| AstraZeneca Pharmaceuticals LP | 12 | $269 |
| Lilly USA, LLC | 7 | $217 |
| Boston Scientific Corporation | 1 | $90 |
| Paratek Pharmaceuticals, Inc. | 4 | $79 |
| Axsome Therapeutics, Inc. | 2 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| PFIZER INC. | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Viatris Specialty LLC | 3 | $48 |
Products named: Ozempic, FARXIGA, ZEPBOUND, AIRSUPRA, JARDIANCE, WATCHMAN FLX, NUZYRA, Auvelity.
Industry payments across NY — which companies pay providers there.
